Ann: Opyl 2020 AGM Presentation, page-3

I listened in to the Zoom Presentation yesterday.

Next year is set to be an exciting year with the launch of two of their AI platforms in clinical trial prediction and recruitment.

The company already has blue chip clients from their social media business and are registered as a market intelligence supplier with Bristol-Myers Squibb.

These companies will have first look into Opyls platforms, the clinical trial design and prediction platform is currently being expanded from 145 to 500+ variables and there is an opportunity for them to upload their own proprietary data into the platform.

The opportunity is speculative especially at this early stage without seeing the full business model. I like the risk equation and I'm surprised the market has this priced to fail.